- Open Access
Exploiting decellularized cochleae as scaffolds for inner ear tissue engineering
Stem Cell Research & Therapyvolume 8, Article number: 41 (2017)
Use of decellularized tissues has become popular in tissue engineering applications as the natural extracellular matrix can provide necessary physical cues that help induce the restoration and development of functional tissues. In relation to cochlear tissue engineering, the question of whether decellularized cochlear tissue can act as a scaffold and support the incorporation of exogenous cells has not been addressed. Investigators have explored the composition of the cochlear extracellular matrix and developed multiple strategies for decellularizing a variety of different tissues; however, no one has investigated whether decellularized cochlear tissue can support implantation of exogenous cells.
As a proof-of-concept study, human Wharton’s jelly cells were perfused into decellularized cochleae isolated from C57BL/6 mice to determine if human Wharton’s jelly cells could implant into decellularized cochlear tissue. Decellularization was verified through scanning electron microscopy. Cocheae were stained with DAPI and immunostained with Myosin VIIa to identify cells. Perfused cochleae were imaged using confocal microscopy.
Features of the organ of Corti were clearly identified in the native cochleae when imaged with scanning electron microscopy and confocal microscopy. Acellular structures were identified in decellularized cochleae; however, no cellular structures or lipid membranes were present within the decellularized cochleae when imaged via scanning electron microscopy. Confocal microscopy revealed positive identification and adherence of cells in decellularized cochleae after perfusion with human Wharton’s jelly cells. Some cells positively expressed Myosin VIIa after perfusion.
Human Wharton’s jelly cells are capable of successfully implanting into decellularized cochlear extracellular matrix. The identification of Myosin VIIa expression in human Wharton’s jelly cells after implantation into the decellularized cochlear extracellular matrix suggest that components of the cochlear extracellular matrix may be involved in differentiation.
Mammals are born with a limited number of functional hair cells (HCs). These cells owe their name to stereocilia that contain ion channels important for signal transduction in the cochlea and therefore for hearing sensation. Unfortunately, mammalian HCs unlike avian HCs do not regenerate after damage . Current HC regeneration research endeavors rely on manipulating gene expression in the sensory epithelium to induce HC development [2–5], differentiating stem cells outside of the body for implantation [6, 7], or using induction methods to differentiate pluripotent stem cells into cochlear organoids [8, 9]. However, while there has been an emphasis on the stem cell differentiation and intracellular gene manipulation [10, 11], could the cochlear extracellular matrix (ECM) play a role in the function of mechanosensory hair cells? Providing structural support for organs and tissues, cell adhesion, differentiation, proliferation, survival, polarity and migration of cells, proteins, and structures of the ECM seem as vital as soluble or genetic signals in governing cell differentiation and tissue formation. The characterization of the cochlear ECM has been well documented [12–14], and several investigators have documented the vital role of the ECM in HC development [15–17]. Natural ECM has been shown to provide valuable inductive signals to guide cell phenotype and tissue regeneration . However, no one has investigated whether cochlear ECM could be beneficial for sensory epithelium regeneration. Thus, there is an opportunity to investigate the potential of using the cochlear ECM as a scaffold to support cell growth and potential development of sensory epithelium engineering applications. Most of the studies on the impact of cochlear ECM on cell behavior are limited to two-dimensional surfaces or pseudo-three-dimensional culture platforms. In order to create an artificial, but nature-oriented three-dimensional microenvironment, multiple factors need to be addressed such as composition, mechanics, porosity, and size. The concept of using decellularized tissue as a scaffold for the development of artificial organs has been used in clinical applications for nearly a decade , but the use of decellularized cochleae has never been used as a scaffold.
The cochlea is one of the smallest but most complex organs of the human body. A huge diversity of cells types and a highly impressive architecture makes regeneration even more complicated. It seems obvious that approaches to regenerate this organ should be guided by scaffolds that not only offer the chemical, but also the physical cues of the ECM including the shape. Santi et al.  have developed a method for decellularizing cochleae (DCs) and creating scaffolds, which is valuable for establishing feasibility. However, the impact of these scaffolds on cells has not been investigated thus far. The advantage of using a DC over a synthetic scaffold is that the cochlea provides the exact physical structure and shape of the extracellular environment in which sensory epithelium develops, whereas other scaffolds must be molded, tuned, or grown to mimic the inside of the cochlea.
The current proof-of-concept study is the first to investigate whether DC cochlea can act as a tissue scaffold and support growth of stem cells. Human Wharton’s jelly cells (hWJCs), multipotent mesenchymal-like stem cells isolated from the umbilical cord, were selected for delivery into DCs, because they have shown the ability in previous studies to differentiate toward a HC phenotype when HATH1 (human homolog of ATOH1) was overexpressed [21–23]. Expression of HATH1 is required for HC commitment [11, 24]. It was hypothesized that the cochlear ECM may provide physical cues that support attachment of hWJCs. The purpose of the current study was to verify that (1) mouse cochleae could successfully be decellularized and (2) determine whether cochlear ECM could support growth of stem cells.
Procurement and decellularization of cochleae
Ten C57BL/6 female mice (approximately 6 weeks old) were euthanized according to approved Institutional Animal Care and Use Committee (IACUC) protocol (ACUP #2014–2234) at University of Kansas Medical Center (KUMC). One mouse was set aside, and fixed via systemic perfusion with 4% paraformaldehyde (VWR, Radnor, PA, USA) in PBS for 1 hour. The mouse was decapitated, and both auditory complexes (cochlea and vestibular organs) were removed via blunt dissection. Cochleae were suspended in PBS, and used as native controls (NC). All other mice were decapitated, and the bulla was removed. The auditory complex of each ear was isolated via blunt dissection for a total of 18 auditory complexes. The stapes was removed from the oval window and the round window membrane was punctured on each cochlea. Each auditory complex (cochlea and vestibular organs) was placed in a separate scintillation vial and perfused with 100 μL 2% penicillin-streptomycin in Hank’s buffered saline solution (HBSS) (Life Technologies, Grand Island, NY, USA) with a 28.5 gauge Ultra-Fine insulin needle and 3 mL syringe (BD Biosciences, San Jose, CA, USA) over a duration of 2 minutes. An additional 400 μL of antibiotic solution was added to each scintillation vial, and auditory complexes were gently agitated for 24 hours on a rotator at 10 rpm.
All subsequent perfusions were performed with fresh 28.5 gauge Ultra-Fine insulin needles and 3 mL syringes (BD Biosciences) and afterward samples were gently agitated on a rotator at 10 rpm for 24 hours, unless otherwise noted.
The following day, auditory complexes were washed with phosphate-buffered saline (PBS) three times. Auditory complexes were carefully perfused with 100 μL of decellularization buffer consisting of 1% SDS in deionized (DI) water (Life Technologies) with fresh changes and perfusions for 3 days. Following decellularization, auditory complexes were washed for 30 min in PBS three times each. Afterward, auditory complexes were perfused with 100 μL of decalcification buffer consisting of 10% EDTA in DI water with daily changes and perfusions for 3 days. Following decalcification, auditory complexes were washed for 30 min in PBS three times. Afterward, auditory complexes were transferred to six-well plates (BD Biosciences) and separated into two groups: (1) control (decellularized cochleae with no cells) or (2) hWJC-DC (decellularized cochleae perfused with hWJCs). Auditory complexes were soaked in a 10% antibiotic-antimycotic solution (Life Technologies) in PBS overnight in a 4 °C refrigerator.
Procurement and expansion of hWJCs
hWJCs were isolated from Wharton’s jelly of human umbilical cords according to the protocols approved by the University of Kansas Human Subjects Committee (KU-Lawrence IRB approval #15402) and Stormont-Vail (SMV) Hospital (SMV IRB approval conferred by IRB Chair, Jo-Ann S. Harris, MD). Nursing staff obtained informed consent from patients before collection of the umbilical cords. Three umbilical cords (n = 3) were obtained from Stormont-Vail (Topeka, KS, USA). All cords were from males that were born at full term and delivered under normal delivery conditions.
hWJCs were isolated and cultured according to previous published protocols . hWJCs were cultured in hWJC medium consisting of 1% penicillin-streptomycin (Life Technologies), 10% fetal bovine serum (FBS) mesenchymal stem cell qualified (MSCq) (Life Technologies), and fibroblast basal medium (Lonza Group Ltd., Basel, Switzerland), and expanded to passage 5 for all experiments.
A subset of hWJCs were divided into two groups: (1) unmodified hWJCs (no transfection) and (2) HATH1-transfected hWJCs. hWJCs were transfected with 0.5 μg HATH1 plasmid DNA according to previous published protocols using a 4D-Nucleofector (Lonza Group Ltd.) at a ratio of 100,000 cells per transfection . Cells were cultured for 7 days in a two-dimensional six-well plate (BD Biosciences). Cells were imaged at 1 and 7 days following transfection and seeding.
Decellularized cochlea perfusion
A total of 6 DCs were reserved as untreated controls. The remaining 12 DCs were presoaked with 37 °C hWJC medium 1 hour prior to perfusion. DCs were perfused with 100 μL containing 100,000 unmodified hWJCs using a 28.5 gauge Ultra-Fine insulin needle and 3 mL syringe (BD Biosciences) in six-well plates (BD Biosciences). Perfusions were administered over a 2-minute duration for each cochlea. After cells were perfused into DCs, 2 mL of prewarmed hWJC medium was added to each well. Perfused cochleae were placed in a 37 °C cell culture incubator. Cochleae were cultured for 7 days and cell culture medium was replaced with 2.5 mL of fresh hWJC medium every 2 days.
After 7 days of culture, cochleae were fixed overnight in 4% paraformaldehyde (VWR) in PBS at 4 °C. NCs, and two control DCs that were not perfused with hWJCs, were stained for 24 hours with 2% osmium tetroxide (OT), because OT embeds between lipids, and produces a strong electron backscatter signal when bombarded by an electron beam. Afterward, OT-stained samples were washed three times for 10 minutes in PBS. All samples were gradually dehydrated with ethanol and cleared in xylene, before being embedded with paraffin. Samples were sectioned to a thickness of 10 μm using a microtome (Leica, Buffalo Grove, IL, USA) and mounted on SuperFrost glass slides (Thermo Fisher Scientific, Waltham, MA, USA).
Scanning electron microscopy
OT-stained samples were deparaffinized in two washes of xylene for 3 minutes each. Afterward, OT samples were critical-point dried in 100% ethanol using an Autosamdri 815B (Tousimis, Rockville, MD, USA). Samples were sputter-coated with 5 nm of copper using a Q150T Turbo-Pumped Sputter Coater (Quorum Technologies, Lewes, UK). Samples were imaged using a Versa 3D Dual Beam electron microscope (FEI, Hillsboro, OR, USA) at a voltage of 30 kV. The Everhart-Thornley detector (ETD) was used to detect secondary electrons while the circular backscatter (CBS) detector was used to detect backscatter electrons. The OT stain was used to detect lipid content (or lack thereof) in biological samples to identify cellular membranes. The aforementioned scanning electron microscopy (SEM) technique enables visual identification and differentiation between cellular and acellular structures within the sample, which allows for confirmation that cochleae have been decellularized. In addition, cells that have been perfused into decellularized tissues can be detected, based on the backscatter signal of the lipids from cellular structures or microvesicles.
After paraffin embedding, samples were deparaffinized in two washes of xylene, and gently rehydrated over 30 minutes with a series of decreasing ethanol solutions in PBS. Samples were incubated in 3% hydrogen peroxide in PBS for 10 minutes at room temperature to block endogenous peroxidase activity. Afterward, samples were washed twice for 5 minutes each with PBS. Samples were incubated twice with 0.2% Tween 20 (Sigma-Aldrich, St. Louis, MO, USA) in PBS for 10 minutes each. Afterward, samples were washed with PBS twice. Samples were blocked for 1 hour with primary blocking solution [6% bovine serum albumin (BSA) (Fisher Scientific, Pittsburgh, PA, USA), 10% normal donkey serum (NDS) (Life Technologies) in PBS]. Afterward, samples were incubated overnight at 4 °C with a dilution of 1:100 primary antibody (Rabbit Anti-Human MYOSIN VIIA (MYO7A) (Cat No: NBP1 84266; Novus Biologicals, Littleton, CO, USA). The following day, samples were washed with PBS three times for 5 minutes each. Samples were incubated overnight with a secondary antibody conjugated to a fluorophore (Donkey Anti-Rabbit Qdot 525 (Cat. No. Q22074; Life Technologies)) at a dilution of 2:100 secondary antibody to secondary blocking solution. The following day, samples were washed three times with PBS for 5 minutes each, and counterstained with DAPI (Life Technologies) according to the manufacturer’s instructions. Afterward, glass coverslips were mounted over samples with Histomount Mounting Solution (Life Technologies) according to the manufacturer’s instructions.
Whole-mount samples were imaged via an Olympus IX81 inverted epifluorescent microscope (Olympus America, Center Valley, PA, USA) at a magnification of × 20. A montage of neighboring fields of view was stitched together in the acquisition software, Slidebook (Intelligent Imaging Innovations [3i], Denver, CO, USA), to create an image of the entire cochlear and vestibular section. Afterward, specific regions of interest were imaged using an Olympus IX81/31 spinning disk confocal microscope (Olympus America) at a magnification of × 40.
Native cochleae revealed anatomical and cellular structures intact
Native cochleae (NC) were imaged via scanning electron microscopy (SEM) using the ETD. Anatomical features of the organ of Corti were clearly discernable (Fig. 1). The tectorial membrane, Reissner’s membrane, outer hair cells, cochlear nerve, spiral ligament, and basilar membrane were clearly identified in NC samples. In DCs, fibrils of the ECM were visible, and the anatomical landmarks such as the basilar membrane, spiral limbus, and spiral ligament were intact (Fig. 2).
No cellular features were detected in decellularized cochleae
No lipid or other cellular structures were detected; however, key features of the cochlear duct were still intact and identifiable, such as the basilar membrane, spiral limbus, and osseous spiral lamina, which suggest that while the decellularization process removed cells, the physical structure of the cochlea remained intact. NCs that were not decellularized displayed a strong backscatter signal, which was consistent with cellular features identified in the organ of Corti, whereas little to no backscatter signal was detected in samples that were decellularized (Fig. 3).
Attachment of hWJCs in decellularized cochleae
The ECM from DCs supported attachment of hWJCs. Multiple regions and surfaces of the DCs were covered with hWJCs after 7 days of culture with the identification of 200 cells or more in whole-mount cochlear sections (Fig. 4). Cells were most commonly detected along the spiral ligament and osseous labyrinth where the stria vascularis existed prior to decellularization. Immunocytochemical staining revealed the presence of MYO7A in some of the hWJCs following 7 days of culture (Fig. 5). To verify MYO7A expression in hWJCs, a culture of unmodified and HATH1-transfected hWJCs were cultured in two-dimensional six-well plates for 7 days (Fig. 6). Only hWJCs transfected with HATH1 displayed MYO7A expression.
Utilizing the decellularization protocol developed by Santi et al. , decellularization of C57BL/6 cochleae were confirmed by different methods, which demonstrated that the protocol used was sufficient for removal of cells. Furthermore, a classic SEM technique was applied in an innovative way to discern cellular and acellular structures within the decellularized cochlea at a high resolution. For the first time DCs were shown to function as a scaffold for attachment of hWJCs. The only cues influencing cell behavior were from the ECM, as the shape and structure of the cochlea were preserved. However, the presence of some cell debris (e.g., proteins) cannot be ruled out as still being present.
The attachment and survival hWJCs into the cochlear ECM suggests that the DC could serve as a tissue scaffold, and potentially be used as a substrate to engineer sensory epithelium. The current study is a first step that could lead to the creation of a model that could be used to analyze how the cochlear ECM supports development and maintenance of sensory epithelium in the cochlea. There is a growing interest in investigating how the ECM of cochlea supports the maintenance and function sensory epithelium. Goodyear and Richardson  and Hayashi et al.  have provided a detailed characterization of the composition of the tectorial membrane from different mammalian species, and have noted how differences in acellular composition and structure of the tectorial membrane affects the function of inner HCs and OCs in the organ of Corti. Furthermore, Liu et al.  have investigated the structure of the basilar membrane, and provided some of the most detailed structural images to date on how the basilar membrane interacts with support cells and changes in width and stiffness from the base to apical end. The potential now exists to examine how the cochlear ECM affects stem cell differentiation independent of bioactive signaling.
Biochemical analysis of the extracellular components in the DC where cells attached could provide critical information about the key molecules involved in HC differentiation, and whether cells have actually incorporated into the matrix or have merely attached. Neuronal path-finding as well as migration and differentiation of cells during embryonic development is supported by cell adhesion molecules [28–30].
While the current study was a proof-of-concept endeavor, there are many aspects of the cochlear ECM left to explore and several aspects left to address, which will enhance the use of DCs as tissue constructs. The visualization of decellularized tissue through SEM and the corroboration of decellularization through assessment of DNA quantity within the decellularized tissue would provide a compelling examination of how thoroughly tissues have (or have not) been decellularized for use in tissue engineering applications. Refinement of decellularization techniques would be prudent for ensuring no debris or cellular epitopes from residual intracellular proteins are present in DCs. It may be possible to improve cell integration into DCs by varying the seeding density of hWJCs. In addition, changing the rate of perfusion or direction of perfusion could improve cell seeding in DCs. Interestingly, the seeding of alternative stem cell types may yield different rates of integration and differentiation potential. Injecting cells through the habenula perforata may allow access to the basilar membrane [31, 32]. Creating serial sections of the DC could additionally yield interesting opportunities to infuse cells from different geometries, and allow for manipulation of several variables in the extracellular environment. Furthermore, the current study is limited by the duration at which perfused cells were assessed. Examining cochleae perfused with hWJCs, or other cell types for greater than 7 days, such as 12 to 15 days, would be advantageous for assessing cell proliferation [using the bromodeoxyuridine (BrdU) assay], and whether any cells are undergoing apoptosis [by terminal deoxynucleotidyl transferase UTP nick-end labeling (TUNEL) assay]. An additional limitation of the study is the assessment of only MYO7A. Quantification of HATH1 expression and identification of additional biomarkers, such as Prestin, miR-96, miR-182, and miR183 would provide greater confidence in the ability of hWJCs to commit to a hair cell phenotype [33, 34]. It remains to be seen if other cell phenotypes found in the sensory epithelium such as support cells and spiral ganglion cells could be identified by assessing expression of Nectin3 and SNAP25, respectively [35, 36]. Follow-up studies which expand the assessment of biomarkers and duration of cells grown in the cochlea could provide valuable information for leveraging the decellularized cochlea as a scaffold for engineering sensory epithelium, and greatly contribute to the trend of using decellularized tissues for regenerative medicine applications.
The current study was a successful first step in developing a tissue construct, which has remarkable technological significance. Culturing cells in the ECM of DCs provides a means to assess the role that the extracellular environment may play in the development and maintenance of sensory epithelium when bioactive signals are absent from host cells. Future studies elucidating how the cochlear ECM supports the development, function, and maintenance of sensory epithelium could provide new insights to sensorineural pathology, which could lead to the development of new strategies for regenerating sensory epithelium including HCs, support cells, and spiral ganglion neurons.
Cochleae were isolated from mice and decellularized.
Decellularization was verified and compared against native controls using an innovative electron microscopy technique.
Major acellular structural features of decellularized cochlea remained intact.
Human Wharton’s jelly cells were successfully seeded into decellularized cochleae.
Bovine serum albumin
Fetal bovine serum
Human homolog of ATOH1
Hank’s buffered saline solution
Human Wharton’s jelly cells
Mesenchymal stem cell qualified
Normal donkey serum
Scanning electron microscopy
Terminal deoxynucleotidyl transferase UTP nick-end labeling
Stone JS, Cotanche DA. Hair cell regeneration in the avian auditory epithelium. Int J Dev Biol. 2007;51(6-7):633–47.
Fukui H, Raphael Y. Gene therapy for the inner ear. Hear Res. 2013;297:99–105.
Izumikawa M, Minoda R, Kawamoto K, Abrashkin KA, Swiderski DL, Dolan DF, Brough DE, Raphael Y. Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med. 2005;11(3):271–6.
Kelly MC, Chang Q, Pan A, Lin X, Chen P. Atoh1 directs the formation of sensory mosaics and induces cell proliferation in the postnatal mammalian cochlea in vivo. J Neurosci. 2012;32(19):6699–710.
Kraft S, Hsu C, Brough DE, Staecker H. Atoh1 induces auditory hair cell recovery in mice after ototoxic injury. Laryngoscope. 2013;123(4):992–9.
Pauley S, Kopecky B, Beisel K, Soukup G, Fritzsch B. Stem cells and molecular strategies to restore hearing. Panminerva Med. 2008;50(1):41–53.
Ronaghi M, Nasr M, Ealy M, Durruthy-Durruthy R, Waldhaus J, Diaz GH, Joubert LM, Oshima K, Heller S. Inner ear hair cell-like cells from human embryonic stem cells. Stem Cells Dev. 2014;23(11):1275–84.
Chen J, Streit A. Induction of the inner ear: stepwise specification of otic fate from multipotent progenitors. Hear Res. 2013;297:3–12.
Longworth-Mills E, Koehler KR, Hashino E. Generating inner ear organoids from mouse embryonic stem cells. Methods Mol Biol. 2016;1341:391–406.
Jahan I, Pan N, Kersigo J, Fritzsch B. Neurod1 suppresses hair cell differentiation in ear ganglia and regulates hair cell subtype development in the cochlea. PLoS One. 2010;5(7):e11661.
Mulvaney J, Dabdoub A. Atoh1, an essential transcription factor in neurogenesis and intestinal and inner ear development: function, regulation, and context dependency. J Assoc Res Otolaryngol. 2012;13(3):281–93.
Gaboyard S, Blanchard MP, Travo C, Viso M, Sans A, Lehouelleur J. Weightlessness affects cytoskeleton of rat utricular hair cells during maturation in vitro. Neuroreport. 2002;13(16):2139–42.
Selva P, Oman CM, Stone HA. Mechanical properties and motion of the cupula of the human semicircular canal. J Vestib Res. 2009;19(3-4):95–110.
Tsuprun V, Santi P. Proteoglycan arrays in the cochlear basement membrane. Hear Res. 2001;157(1-2):65–76.
Davies D. Cell-extracellular matrix versus cell-cell interactions during the development of the cochlear-vestibular ganglion. J Neurosci Res. 2011;89(9):1375–87.
Gerchman E, Hilfer SR, Brown JW. Involvement of extracellular matrix in the formation of the inner ear. Dev Dyn. 1995;202(4):421–32.
Szarama KB, Gavara N, Petralia RS, Kelley MW, Chadwick RS. Cytoskeletal changes in actin and microtubules underlie the developing surface mechanical properties of sensory and supporting cells in the mouse cochlea. Development. 2012;139(12):2187–97.
Renth AN, Detamore MS. Leveraging “raw materials” as building blocks and bioactive signals in regenerative medicine. Tissue Eng Part B Rev. 2012;18(5):341–62.
Bader A, Macchiarini P. Moving towards in situ tracheal regeneration: the bionic tissue engineered transplantation approach. J Cell Mol Med. 2010;14(7):1877–89.
Santi PA, Johnson SB. Decellularized ear tissues as scaffolds for stem cell differentiation. J Assoc Res Otolaryngol. 2013;14(1):3–15.
Devarajan K, Forrest ML, Detamore MS, Staecker H. Adenovector-mediated gene delivery to human umbilical cord mesenchymal stromal cells induces inner ear cell phenotype. Cell Reprogram. 2013;15(1):43–54.
Kil K, Choi MY, Park KH. In vitro differentiation of human Wharton’s jelly-derived mesenchymal stem cells into auditory hair cells and neurons. J Int Adv Otol. 2016;12(1):37–42.
Mellott AJ, Devarajan K, Shinogle HE, Moore DS, Talata Z, Laurence JS, Forrest ML, Noji S, Tanaka E, Staecker H, et al. Nonviral reprogramming of human Wharton’s jelly cells reveals differences between ATOH1 homologues. Tissue Eng Part A. 2015;21(11-12):1795–809.
Driver EC, Sillers L, Coate TM, Rose MF, Kelley MW. The Atoh1-lineage gives rise to hair cells and supporting cells within the mammalian cochlea. Dev Biol. 2013;376(1):86–98.
Goodyear RJ, Richardson GP. Extracellular matrices associated with the apical surfaces of sensory epithelia in the inner ear: molecular and structural diversity. J Neurobiol. 2002;53(2):212–27.
Hayashi H, Schrott-Fischer A, Glueckert R, Liu W, Salvenmoser W, Santi P, Rask-Andersen H. Molecular organization and fine structure of the human tectorial membrane: is it replenished? Cell Tissue Res. 2015;362(3):689–90.
Liu W, Atturo F, Aldaya R, Santi P, Cureoglu S, Obwegeser S, Glueckert R, Pfaller K, Schrott-Fischer A, Rask-Andersen H. Macromolecular organization and fine structure of the human basilar membrane - RELEVANCE for cochlear implantation. Cell Tissue Res. 2015;360(2):245–62.
Hrynkow SH, Morest DK, Bilak M, Rutishauser U. Multiple roles of neural cell adhesion molecule, neural cell adhesion molecule-polysialic acid, and L1 adhesion molecules during sensory innervation of the otic epithelium in vitro. Neuroscience. 1998;87(2):423–37.
Whitlon DS, Zhang X, Kusakabe M. Tenascin-C in the cochlea of the developing mouse. J Comp Neurol. 1999;406(3):361–74.
Whitlon DS, Zhang X, Pecelunas K, Greiner MA. A temporospatial map of adhesive molecules in the organ of Corti of the mouse cochlea. J Neurocytol. 1999;28(10-11):955–68.
Kano M. An experimental study of tumor cell infiltration into temporal bones--route into the inner ear from the arachnoid space. Nihon Jibiinkoka Gakkai Kaiho. 1998;101(7):884–94.
Sekiya T, Kojima K, Matsumoto M, Kim TS, Tamura T, Ito J. Cell transplantation to the auditory nerve and cochlear duct. Exp Neurol. 2006;198(1):12–24.
Sacheli R, Nguyen L, Borgs L, Vandenbosch R, Bodson M, Lefebvre P, Malgrange B. Expression patterns of miR-96, miR-182 and miR-183 in the development inner ear. Gene Expr Patterns. 2009;9(5):364–70.
Zheng J, Shen W, He D, Long K, Madison L, Dallos P. Prestin is the motor protein of cochlear outer hair cells. Nature. 2000;405(6783):149–55.
Darrow KN, Simons EJ, Dodds L, Liberman MC. Dopaminergic innervation of the mouse inner ear: evidence for a separate cytochemical group of cochlear efferent fibers. J Comp Neurol. 2006;498(3):403–14.
Wan G, Corfas G, Stone JS. Inner ear supporting cells: rethinking the silent majority. Semin Cell Dev Biol. 2013;24(5):448–59.
We would like to acknowledge the efforts of Peggy Keefe and the nursing staff at Stormont-Vail Hospital (Topeka, KS, USA) for assisting us in obtaining human umbilical cords.
This project was funded by National Institutes of Health (NIH) R01 AR056347 and the State of Kansas.
Availability of data and materials
All data generated or analyzed supporting conclusions are included in the current manuscript.
The idea to perfuse modified and unmodified hWJCs into decellularized cochleae was conceived by AJM. The initial experiments were developed by AJM, HES, JGN, MSD, and HS. The experiments were executed by AJM, HES, and JGN. The manuscript was written by AJM, and edited and revised by HES, JGN, MSD, and HS. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Ethics approval and consent to participate
C57BL/6 female mice (approximately 6 weeks old) were euthanized according to Animal Care Use Protocol (ACUP #2014-2234), approved by the University of Kansas Medical Center (KUMC) Institutional Animal Care and Use Committee (IACUC).
hWJCs were isolated from Wharton’s jelly of human umbilical cords according to the protocols approved by the University of Kansas Human Subjects Committee (KU-Lawrence IRB approval #15402) and Stormont-Vail (SMV) Hospital (SMV IRB approval conferred by IRB Chair, Jo-Ann S. Harris, MD). Informed consent was obtained from all participants in the study.